22157.jpg
Global Cell Therapy Market Report 2021-2028 - Growing Adoption of Regenerative Medicine & Introduction of Novel Platforms and Technologies
October 22, 2021 06:13 ET | Research and Markets
Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Market Size, Share & Trends Analysis Report by Use-type, by Therapy Type (Autologous, Allogenic), by Region (North America,...
Cryo-Cell International, Inc. logo
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results
October 15, 2021 16:36 ET | Cryo-Cell International, Inc.
OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store...
22157.jpg
Insights on the Cell Therapy Consumables Global Market to 2031 - Industry Trends and Forecasts
October 12, 2021 06:53 ET | Research and Markets
Dublin, Oct. 12, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Consumables Market by Type of Consumable, Type of Cell Therapy, Scale of Operation, Type of End-User and Key Geographical Regions:...
Cryo-Cell International, Inc. logo
Cryo-Cell International Announces Changes To Its Board of Directors
September 20, 2021 18:05 ET | Cryo-Cell International, Inc.
MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark...
22157.jpg
Global Cell Therapy Market Opportunity: USD 45 Billion+ By 2028
September 06, 2021 04:23 ET | Research and Markets
Dublin, Sept. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Market Outlook, Patent & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. In last...
Cryo-Cell International, Inc. logo
Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market
August 30, 2021 09:00 ET | Cryo-Cell International, Inc.
Cryo-Cell International, Inc. (Symbol CCEL), The Leader In Cord Blood And Cord Tissue Cryopreservation Services, Today Announced That The Company’s Common Stock Has Been Approved For Listing On The...
Rubius_Logo.jpg
Rubius Therapeutics Appoints Jim Jogerst as Chief Business Officer
August 30, 2021 08:00 ET | Rubius Therapeutics
CAMBRIDGE Mass., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an...
Cryo-Cell International, Inc. logo
Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies
August 20, 2021 09:04 ET | Cryo-Cell International, Inc.
Cryo-Cell International (symbol: CCEL) Purchases Real Estate Location for its Institute for Cellular Therapies in the Raleigh-Durham area. MIAMI, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell...
Cryo-Cell International, Inc. logo
Cryo-Cell International to Present at the Q3 Virtual Investor Summit
August 11, 2021 09:00 ET | Cryo-Cell International, Inc.
MIAMI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International announces that Chairman of the Board and Co-CEO, David Portnoy, will be presenting at the Q3 Virtual Investor Summit on August 18th,...
22157.jpg
Outlook on the Cell Therapy Manufacturing Global Market to 2030 - Industry Trends and Forecasts
August 11, 2021 07:48 ET | Research and Markets
Dublin, Aug. 11, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Manufacturing Market by Type of Cell Manufactured, Source of Cell, Scale of Operation, Purpose of Manufacturing and Key Geographical...